Press "esc" to clear
Go to Advanced Search

Showing results

110 of 268
Embargo will expire:
18-Nov-2018 4:45 PM EST
Released to reporters:
13-Nov-2018 12:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Nov-2018 4:45 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 703671

Oral Antibiotic Treatment Option for Gonorrhea Identified by UAB Researchers

University of Alabama at Birmingham

Scientists have found that a single-dose of the oral antibiotic zoliflodacin successfully treated uncomplicated genital infections caused by gonorrhea, according to research published in The New England Journal of Medicine.

Released:
8-Nov-2018 4:05 PM EST

Article ID: 703634

Case Western Reserve-Led Study Triggers Change in WHO Guidelines for Treating Lymphatic Filariasis, Now Targeted for Elimination

Case Western Reserve University

Researchers from Case Western Reserve University School of Medicine have shown that a single “cocktail” of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic filariasis, commonly known as elephantiasis, than other standard two-drug combinations previously used in the global effort to eliminate this infectious disease. A combination of all three drugs given simultaneously had never been tested until now. An estimated 120 million people in over 50 tropical and subtropical countries are infected with lymphatic filariasis and another 856 million people are at risk.

Released:
8-Nov-2018 11:05 AM EST

Article ID: 703466

New Checkpoint Inhibitor Shows Promise in Clinical Trial for Non-Hodgkin’s Lymphoma

University of Chicago Medical Center

By combining the experimental anti-cancer antibody known as 5F9 with the anti-cancer antibody rituximab, researchers managing a phase 1b clinical trial were able to induce a positive response in 11 out of 22 people with relapsed/refractory non-Hodgkin’s lymphoma. Eight of the 22 patients went into complete remission from their cancers.

Released:
6-Nov-2018 10:05 AM EST

Article ID: 703198

Cluster of Cocaine-Fentanyl Overdoses in Philadelphia Underscores Need for More “Test Strips” and Rapid Response

Perelman School of Medicine at the University of Pennsylvania

Penn Medicine emergency department physicians are calling for more readily available testing strips to identify the presence of fentanyl in patients experiencing a drug overdose, and a rapid, coordinated response among health care providers and city agencies to help curb overdoses and identify high potency high risk drugs.

Released:
1-Nov-2018 12:10 PM EDT
  • Embargo expired:
    31-Oct-2018 5:00 PM EDT

Article ID: 703030

For Early Cervical Cancer, Open Hysterectomy is Safer than Minimally Invasive Surgery

Columbia University Irving Medical Center

A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.

Released:
30-Oct-2018 10:05 AM EDT
  • Embargo expired:
    31-Oct-2018 5:00 PM EDT

Article ID: 703071

Minimally Invasive Surgery Associated with Worse Survival for Women with Cervical Cancer Compared to Open Hysterectomy

University of Texas M. D. Anderson Cancer Center

When comparing standard-of-care surgical options for women with early-stage cervical cancer, two studies led by researchers at The University of Texas MD Anderson Cancer Center discovered that minimally invasive radical hysterectomy is associated with higher recurrence rates and worse overall survival (OS), compared to abdominal radical hysterectomy.

Released:
30-Oct-2018 5:00 PM EDT
NEJMrelapsedAMLfirstauthors.jpg
  • Embargo expired:
    31-Oct-2018 5:00 PM EDT

Article ID: 703113

Relapsed leukemia flies under immune system’s radar

Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis offers a potential explanation for why many AML patients experience a relapse after a stem cell transplant, and suggests a therapeutic approach that may help to place relapsed patients back into remission.

Released:
30-Oct-2018 6:05 PM EDT

Article ID: 702565

Antipsychotics Ineffective For Treating ICU Delirium

Vanderbilt University Medical Center

Critically ill patients are not benefitting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine.

Released:
22-Oct-2018 11:05 AM EDT
LeishaEmensHR.jpg

Article ID: 702533

Treatment of Aggressive Breast Cancer Improved by Immunotherapy-Chemotherapy Combination

Health Sciences at the University of Pittsburgh

Progression free survival in triple-negative breast cancer increased when immunotherapy-chemotherapy treatment combination is used as the first treatment option.

Released:
20-Oct-2018 4:05 PM EDT

Showing results

110 of 268

Chat now!